The omnipresence of DYRK1A in human diseases

E Deboever, A Fistrovich, C Hulme… - International journal of …, 2022 - mdpi.com
The increasing population will challenge healthcare, particularly because the worldwide
population has never been older. Therapeutic solutions to age-related disease will be …

A computational approach applied to the study of potential allosteric inhibitors protease NS2B/NS3 from dengue virus

RA Costa, JAP Rocha, AS Pinheiro, ASS Costa… - Molecules, 2022 - mdpi.com
Dengue virus (DENV) is a danger to more than 400 million people in the world, and there is
no specific treatment. Thus, there is an urgent need to develop an effective method to …

Computational Modeling of Kinase Inhibitors as Anti-Alzheimer Agents

P De, K Roy - Computational Modeling of Drugs Against Alzheimer's …, 2023 - Springer
Alzheimer's disease (AD) is a progressive neurodegenerative disease distinguished by
memory loss, cognitive dysfunction, impaired functional abilities, and behavioral changes …

Novel efficient multistage lead optimization pipeline experimentally validated for DYRK1B selective inhibitors

V Alexandrov, M Vilenchik, O Kantidze… - Journal of Medicinal …, 2022 - ACS Publications
In addition to general challenges in drug discovery such as the identification of lead
compounds in time-and cost-effective ways, specific challenges also exist. Particularly, it is …

Searching of Novel herbicides for paddy field weed management—a case study with acetyl-CoA carboxylase

A Antony, R Karuppasamy - Agronomy, 2022 - mdpi.com
Weed management is the major biological constraint in paddy (Oryza sativa L.) producing
areas. Predominantly, barnyard grass (Echinochloa crus-galli) is a rice-mimicking weed that …

A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization—explanation of its folded conformation

R Moreno-Fuquen… - Royal Society …, 2025 - royalsocietypublishing.org
Chronic myeloid leukaemia (CML) is primarily treated using imatinib mesylate, a tyrosine
kinase inhibitor (TKI) targeting the BCR:: ABL1 oncoprotein. However, the development of …

Disruption of DYRK1A-induced hyperphosphorylation of amyloid-beta and tau protein in Alzheimer's disease: An integrative molecular modeling approach

R Shukla, A Kumar, DJ Kelvin… - Frontiers in Molecular …, 2023 - frontiersin.org
Alzheimer's disease (AD) is a neurological disorder caused by the abnormal accumulation
of hyperphosphorylated proteins. Dual-specificity tyrosine phosphorylation-regulated kinase …

Structure based interaction and molecular dynamics studies of cysteine protease Cathepsin B against curcumin and resveratrol

M Nandhini, C Pitchumani Violet Mary… - Journal of …, 2024 - Taylor & Francis
The lysosomal cysteine peptidase Cathepsin B is identified as a pivotal contributor to cancer
development. In the pursuit of discovering less toxic inhibitors for Cathepsin B, various …

Computational Modeling of DYRK1A Inhibitors as Potential Anti-Alzheimer Agents

E Serrano-Candelas, LE Carpio… - Computational Modeling of …, 2023 - Springer
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a promising
target for the treatment of different neurodegenerative diseases, especially Alzheimer's …

An integrated machine learning-based virtual screening strategy for biological weeding in maize field: a case study with HPPD

A Antony, R Karuppasamy - Journal of Plant Diseases and Protection, 2023 - Springer
The habitancy of maize crops endorses a broad spectrum of post-emergence weeds. Of
note, 4-hydroxyphenylpyruvate dioxygenase (HPPD) is regarded as a promising herbicidal …